{"name":"Chuan An Biotechnology Co., Ltd.","slug":"chuan-an-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CIK Cell","genericName":"CIK Cell","slug":"cik-cell","indication":"Treatment of various types of cancer, including leukemia, lymphoma, and solid tumors","status":"phase_2"}]}],"pipeline":[{"name":"CIK Cell","genericName":"CIK Cell","slug":"cik-cell","phase":"phase_2","mechanism":"CIK cells are a type of adoptive cell therapy that stimulate the immune system to attack cancer cells.","indications":["Treatment of various types of cancer, including leukemia, lymphoma, and solid tumors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-03","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQMFQ3MXJvalFmQmh0QkhFbE96ZTNPSno4SjdDWHQtYXdwTUpuUnF1TGRyT3JBRTIzSVBYamJkS1M1THI2QmU0ZnVIMG00MzBZdm5BcWpZckpRX1JjbE5WRGVER25aQm5OQ2d3OUIwUklBbTFQdDlPQnNWSjd5cy1tRDBaRmVQc3lkdTVRNW12VnBQV284blVHRGhfdjI4RmtMTFJHaWpnREpjeEM5RDI4V0VjaE1uXzRUUWV4ZTB3?oc=5","date":"2026-03-31","type":"pipeline","source":"Markets Mojo","summary":"Yili Chuannig Biotechnology Hits Day High with Strong 5.04% Surge - Markets Mojo","headline":"Yili Chuannig Biotechnology Hits Day High with Strong 5.04% Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOaUg4UXkzV2RwSnhEaTVwVUJTY1NsaGl1LVBzYklRdGhVcDNoV1hHLU04NTR3dEJuZ3FLVHN2RnBkd0Raa081cEI4V2VHRURBZkRoWl9XLXNJUThSLUVnMFptSTgzd3RkNjl5RFpXNzJEVUs5MmxjTWlVYTgzRkY5dmxnYzJIZWtuLUQ1TzVoQ05kbU82?oc=5","date":"2024-02-10","type":"pipeline","source":"Frontiers","summary":"Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats - Frontiers","headline":"Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}